{"name":"Enterome","slug":"enterome","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE0tRG1EMkFkTi16NDdDQ3Q4THI5c1FXSF94SzZoVWtlRWxXc3E0N21WcHUzdHA2UzlBY2RZTFpBV0I3bjBZeWIwa1llWDdaVkt5TllVS29icXFiT2pFSjdEWDNsTlhXU2tFcklUUmNZem1fcGdVeHc?oc=5","date":"2025-10-28","type":"pipeline","source":"Labiotech.eu","summary":"11 microbiome biotech companies to watch in 2025 - Labiotech.eu","headline":"11 microbiome biotech companies to watch in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxON0s3Um5USm5yd1F1NC1hWGptMFhtQ0ZaTEFkLWNqbzZUMlVlY0JBLW1OLVFyUGJiVWxqSEZJbDQzeloydkRrdTBkRWhTclZ3NkhMcmp6ZnFkWnh5MU11TTNZb20xX0tyNzh5S3N0RmtmWi1WcUY5ejZhOEEtXzhEMVRxQ3d4Zi1BenItNHpQQVgxelZQZ3NOeHB2dk81cU9qQ2daRw?oc=5","date":"2025-10-16","type":"regulatory","source":"PharmaTimes","summary":"FDA grants fast Track status to Enterome’s EO2463 for follicular lymphoma - PharmaTimes","headline":"FDA grants fast Track status to Enterome’s EO2463 for follicular lymphoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxObVQ2dkdobXhRWFRGMFY3a19hdzNrSVNuRTlWeUR0MEFXb1pCM3ZOM2xqeWJVMVhkM25lU014dUVqaUZsRlJOdXBjLTJoeklfeUFfX3dMdUdGWjkyM28zYUlydFB0N0FFbVBmdGNTeGZFbUpBckhjMmY2SHNYbGl6eVVXdw?oc=5","date":"2025-06-12","type":"pipeline","source":"Pharmaceutical Technology","summary":"Enterome to advance EO2463 immunotherapy with $19m funding - Pharmaceutical Technology","headline":"Enterome to advance EO2463 immunotherapy with $19m funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNRUJvWUtTTmstSTVIYWlBRkRSQmFzS256LWN1ZWpFR25JTV8tSGFNMnB1TWdDeXZ3bzMwUDBXUk1yV3pVcFdZdVFtMmVsRklNNlZrNjd3ek9ham96YThlWUU2Y1dlMVF6WnpQVEU0R3FKLUgzdXl0QWdWd2NuaEZ2aGFWS2drOXJlUnZxTm1pRVJ3Vm9EcXZlZklmaE5GYjNUQW9DUmN5N3pTdGtaeHUzN25VMHJxM2dPUHA0dFlvY2xkSXhkVnBPWlppb1hJR0pYOWw0cm84Sno1X3JDR1BwNjln?oc=5","date":"2025-01-22","type":"pipeline","source":"BioSpace","summary":"Adrenal Cortex Neoplasms Market to Reach USD 29.8 Million by 2035, Impelled by Development of Novel Therapies - BioSpace","headline":"Adrenal Cortex Neoplasms Market to Reach USD 29.8 Million by 2035, Impelled by Development of Novel Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxQLUdGNExlVk1Yb25WMVhZWUlQUzgteV93WGRaSHU4WWZzMDFUYURLQXV5dFdHM3JTcERzSVQ5eUlLOFRSTXFsak8xdFJ4RmpHblB6YXJWY0tXMnhrQWluUk5OTkRqWTZvWHB0UkUyMndISW9XSS1tNDhnTDVnZmVxZm1lWUVLM3VVb2Y0dzJ2ZDExNWlhNk84RERxRkJSY2RubzhfSHZPZ3JpQ1NhSWV3ODltTlc3TF9ZWlV4LXFNWV9EdFlOT1RQNnFGeVotT3l3LWhmd2Z1Y19DcmtfQzJqdDlSaFlsZWJhWmlPMVluVkIzTmRPcTQxcDZ1UkhicGVfQUFqZ3QtZHVfTEQ1RXB4UmFkVkRmeXduUU1XQzM2YU5Jb002cnNpb01B?oc=5","date":"2024-11-28","type":"trial","source":"prnewswire.com","summary":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - prnewswire.com","headline":"Follicular Lymphoma Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Therape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPTUhZZ203eXNMaGxrWGRzaXZQR2RRaENvZk1FSndyZ1k2VXUxcVJ4OHJ2dU5SUC1XUE9Iclk3WjlFWFB3SGtuRWh2UHVIZjdDc2hfSDU4MkVMN1VNVndlZ1pXYUlqemplT2hhc3ZYTE1JMEhub2JMLTlYVVBkS2psMUlhTEdqU0k0TC04aDhlbEJianZtbEJLejFLcEFTWm5RWE5pLW50M1lTX3lQ?oc=5","date":"2023-10-19","type":"trial","source":"Fierce Pharma","summary":"Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn's complication - Fierce Pharma","headline":"Takeda’s stem cell treatment Alofisel flunks phase 3 trial in Crohn's complication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQYmJBWjdtTWRsdXkwckxjcjUxUkF0Tjd1c3c5NkpQa2poS1RrQUsxdkF5YXdWWVcyY2xnMzBPVGcyRUdpWHB3UzA1UERvbld6eVl6UzNQWFczVmw5c01sRjhRZnZPSGMxc1RNSXNTOW9JWFZkTE9PNTJ4ZlhTS0dYSXJXSGVJS2JvaXZsSWRQRzIzcnFxOUVKTGtkZHJ6dVVJQmxjUlQ2NnltU3JPU0hOQmJ4XzAwSWlJdVhGT2taTkQ?oc=5","date":"2023-08-25","type":"trial","source":"Pharmaceutical Technology","summary":"Microbiome company Enterome plans $108m raise to fund Phase II cancer trials - Pharmaceutical Technology","headline":"Microbiome company Enterome plans $108m raise to fund Phase II cancer trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNbjZXZ3o1R3M3d0pYTlFRb0h4NUY4LXBMa3Z0Qi1vOTlMYUstSHdPRmRDUHRIelZWcnY1Zm52R3lPbjVSY3g3eDBVdm5pcUpRc05KNHlybWpPVnFWWFNfbndjNERoRlVobzJwS2tzSnhBbHNrOHVuMGlBR2VSSkFnOWN4VVVvSEpJVTNLVDZOc0Ytelo3MHA1S3BxTjJGOU5XTVkzZXBCVlV1cUxwaV93NktSbTVJS0loX0hqcg?oc=5","date":"2023-05-11","type":"pipeline","source":"fiercebiotech.com","summary":"Takeda cuts 2 midstage GI assets including Crohn's hopeful in latest pipeline cleanup - fiercebiotech.com","headline":"Takeda cuts 2 midstage GI assets including Crohn's hopeful in latest pipeline cleanup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBiTmlMQTgzQk5GNjRCSlNLemdaemstWjBzT0kzNDJHczFHbDdBZDM0RGZOaXNPOXh3M1MtRmFuR2p5X19TeDdqNndGNUZacUxmYjdxLUVpR3VfZnV2eWxN?oc=5","date":"2022-12-01","type":"pipeline","source":"Nature","summary":"Rehabilitating the immune system to address allergies - Nature","headline":"Rehabilitating the immune system to address allergies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNOXhfcHEtaEZIMjM1dEJPUDZhQ2QtRE93cUhUZEJ6MUJvbFd0bzg0anJwUG1henJlVkhvZFFkV2U0RDdoUmtOYzc2ZkNWR08zckMwdV9HZHR6YjgxYkJJVHJVT2RiOUhxcGdMTXBkbWNrZUpkWWNTazVvbmR6bzZJZ25PTDExTnlYNWpPVlRYejU?oc=5","date":"2022-07-18","type":"deal","source":"BioPharma Dive","summary":"Nestlé expands microbiome drug work with biotech deal - BioPharma Dive","headline":"Nestlé expands microbiome drug work with biotech deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPeHRKZXY1QTdqN3hweDR5SUVMby1IZ0ZhRHF6d0RjS09fQVYzSGhxc3FDRWx3VWhqQ1NXRHU0THlIbzBFNFEwMm14Yjh3MHZvb3lieWVhOUZUaW5HeTUtNnZVTTk1VC1RNkxwVVFlczhVVlNjc0ZGYWVoSFBHMWthMg?oc=5","date":"2020-06-25","type":"pipeline","source":"FinSMEs","summary":"Enterome Closes €46.3M Financing Round - FinSMEs","headline":"Enterome Closes €46.3M Financing Round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPWkRWNlFpSmFEWUFmcFpXUUpET3FnS3RjUk9QUUdycG9sR0ZjYzVwcF9TNFRpd3BlSlQ5SnlTR0xqTHRtUzh6WXpqNWNHalcwaXpDSV9FX3kwOVFWZWRoUlpXNFNFeGI4OTRyVWZoYm1MaWx1WjBiRHNvcDA0amgwMWVyX2NueWVYVGp6TFRQUVh1X1c4cFN1Znln?oc=5","date":"2015-09-29","type":"regulatory","source":"Pharmafile","summary":"Georges Gemayel appointed non-executive chairman of Enterome - Pharmafile","headline":"Georges Gemayel appointed non-executive chairman of Enterome","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}